St. Jude Medical Named FORTUNE Magazine's Most Admired Medical And Other Precision Equipment Company For Second Consecutive Year

Main Category: Public Health
Article Date: 04 Mar 2008 - 15:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

St. Jude Medical, Inc. (NYSE:STJ) announced that FORTUNE Magazine has named it one of "America's Most Admired Companies" for 2008. St. Jude Medical ranked No. 1 in the Medical and Other Precision Equipment category for the second year in a row.

St. Jude Medical has been named to FORTUNE's Most Admired Companies list in each of the last four years.

"We are honored to again be recognized among America's most admired companies by one of the world's most admired publications," said Daniel J. Starks, chairman, president and CEO of St. Jude Medical. "Our designation as the number one most admired medical equipment company is a testament to the dedication of our 12,000 St. Jude Medical employees who make life better for cardiac, neurological and chronic pain patients worldwide."

FORTUNE surveyed more than 15,000 top executives, directors and members of the financial community to develop the rankings. The magazine uses a rigorous assessment to determine a company's overall reputation. St. Jude Medical ranked either first or second in the medical equipment category for each of the magazine's eight areas of assessment:

-- Innovation
-- People management
-- Use of corporate assets
-- Social responsibility
-- Quality of management
-- Financial soundness
-- Long-term investment
-- Quality of products/services

The "Most Admired Companies" list is included in the March 17 issue, available on newsstands March 10 and available online.

About St. Jude Medical

St. Jude Medical is dedicated to making life better for cardiac, neurological and chronic pain patients worldwide through excellence in medical device technology and services. The Company has five major focus areas that include: cardiac rhythm management, atrial fibrillation, cardiac surgery, cardiology and neuromodulation. Headquartered in St. Paul, Minn., St. Jude Medical employs approximately 12,000 people worldwide. For more information, please visit http://www.sjm.com.

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. Such forward-looking statements include the expectations, plans and prospects for the Company, including potential clinical successes, anticipated regulatory approvals and future product launches, and projected revenues, margins, earnings, and market shares. The statements made by the Company are based upon management's current expectations and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include market conditions and other factors beyond the Company's control and the risk factors and other cautionary statements described in the Company's filings with the SEC, including those described in the Company's Annual Report on Form 10-K filed on February 27, 2008 (see Item 1A on pages 13-20, and page 20 of Exhibit 13 to the Company's Form 10-K). The Company does not intend to update these statements and undertakes no duty to any person to provide any such update under any circumstance.

St. Jude Medical